Bafna Pharmaceuticals Ltd.

BAFNAPH

₹72.75

1.54% (1.1)

Market Cap

₹170 Cr.

P/E

39.64

About

Bafna Pharmaceuticals Ltd specializes in the production of tablets, capsules, and oral syrup. They primarily focus on prescription drugs in the global market and offer services such as contract manufa… Read more

Bafna Pharmaceuticals Ltd specializes in the production of tablets, capsules, and oral syrup. … Read more

Low

52W Range

High

100

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Bafna Pharmaceuticals Ltd. Business

What does Bafna Pharma do?

Bafna Pharmaceuticals Ltd specializes in manufacturing tablets, capsules, and oral syrups, focusing on prescription drugs for the global market. They offer contract manufacturing services and a wide range of pharmaceutical categories.

Who are the competitors of Bafna Pharma?

Bafna Pharma major competitors are IndoAmerican Advance, Syschem (India), Amwill Health Care, Quest Laboratories, Krebs Biochem.&Inds, Panchsheel Organics, Vaishali Pharma.
Market Cap of Bafna Pharma is ₹170 Crs.
While the median market cap of its peers are ₹164 Crs.

Is Bafna Pharma financially stable compared to its competitors?

Bafna Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Bafna Pharma is 3.51 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd.

About

Timeline

Company Timeline

8 Yes

2 Neutral

7 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Retail Holding

Promoter Holding

Revenue Recognition

Price & Performance

ROE

Current vs Historic Valuation

Sales Growth

Balance Sheet Strength

Capex vs ROCE

Debt

Share price

Working Capital

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

What does Bafna Pharma do?

Who are the competitors of Bafna Pharma?

Is Bafna Pharma financially stable compared to its competitors?

SIGN UP FOR FREE